Dark Pharma · DP-017
SHE FOUND THE DUPLICATES IN MARCH. THE TRIALS HAD ALREADY DOSED NINE HUNDRED PATIENTS. THE COMPANY KNEW IN JANUARY.
In March 2021, Dr. Amara Okonkwo uncovered systematic image manipulation in studies that supported the Alzheimer's drug Memorex, revealing 17 duplications across four publications. Nine hundred patients had already begun Phase 3 trials, with their families citing these flawed studies for consent.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.
Dark Sport
DS-001
He Obtained The Phone Records In 2006. The Championship Had Already Be...
Shared: Whistleblower Protection, Transparency Protocols
Dark Pharma
DP-042
The Internal Data Showed The Weight Gain. The Marketing Said Something...
Shared: Whistleblower Protection
Dark Tech
DT-050
The Algorithm Flagged Her Application As Fraud. She Lost Her Children ...
Shared: Transparency Protocols
Dark Sport
DS-036
They Passed The Urine Samples Through A Hole In The Wall. Russia Toppe...
Shared: Whistleblower Protection